Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1473224/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850054537317974016 |
|---|---|
| author | Magdy Mohamed Allam Ramy Mohamed Ghazy Ramy Mohamed Ghazy Hanaa Tarek Hussein Elzawawy |
| author_facet | Magdy Mohamed Allam Ramy Mohamed Ghazy Ramy Mohamed Ghazy Hanaa Tarek Hussein Elzawawy |
| author_sort | Magdy Mohamed Allam |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9bc37a856470442389509476e7204ad9 |
| institution | DOAJ |
| issn | 1664-2392 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Endocrinology |
| spelling | doaj-art-9bc37a856470442389509476e7204ad92025-08-20T02:52:13ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922024-12-011510.3389/fendo.2024.14732241473224Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trialMagdy Mohamed Allam0Ramy Mohamed Ghazy1Ramy Mohamed Ghazy2Hanaa Tarek Hussein Elzawawy3Internal Medicine Department, Alexandria University Student Hospital (AUSH), Alexandria, EgyptTropical Health Department, High Institute of Public Health Alexandria University, Alexandria, EgyptFamily and Community Medicine Department, College of Medicine, King Khalid University, Abha, Saudi ArabiaInternal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, Egypthttps://www.frontiersin.org/articles/10.3389/fendo.2024.1473224/fullazathioprinehyperthyroidismremissionGraves'severe |
| spellingShingle | Magdy Mohamed Allam Ramy Mohamed Ghazy Ramy Mohamed Ghazy Hanaa Tarek Hussein Elzawawy Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial Frontiers in Endocrinology azathioprine hyperthyroidism remission Graves' severe |
| title | Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial |
| title_full | Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial |
| title_fullStr | Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial |
| title_full_unstemmed | Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial |
| title_short | Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial |
| title_sort | response commentary azathioprine as an adjuvant therapy in severe graves disease a randomized controlled open label clinical trial |
| topic | azathioprine hyperthyroidism remission Graves' severe |
| url | https://www.frontiersin.org/articles/10.3389/fendo.2024.1473224/full |
| work_keys_str_mv | AT magdymohamedallam responsecommentaryazathioprineasanadjuvanttherapyinseveregravesdiseasearandomizedcontrolledopenlabelclinicaltrial AT ramymohamedghazy responsecommentaryazathioprineasanadjuvanttherapyinseveregravesdiseasearandomizedcontrolledopenlabelclinicaltrial AT ramymohamedghazy responsecommentaryazathioprineasanadjuvanttherapyinseveregravesdiseasearandomizedcontrolledopenlabelclinicaltrial AT hanaatarekhusseinelzawawy responsecommentaryazathioprineasanadjuvanttherapyinseveregravesdiseasearandomizedcontrolledopenlabelclinicaltrial |